|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.34 EUR | -0.64% |
|
+0.54% | -4.90% |
| 04-27 | Emeis, Exosens, Thales... stocks to watch today in Paris | |
| 04-27 | French and Benelux stocks-Factors to watch Monday April 27 | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 9.44 | 5.85 | 4.27 | 5.15 | 5.51 | |||||
Return on Total Capital | 11.82 | 7.28 | 5.2 | 6.21 | 6.69 | |||||
Return On Equity % | 18.66 | 12.72 | 6.16 | 7.71 | 9.5 | |||||
Return on Common Equity | 17.95 | 12.32 | 5.2 | 6.84 | 8.42 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.49 | 22.74 | 21.1 | 22.45 | 22.49 | |||||
SG&A Margin | 0.19 | 0.21 | 0.2 | 0.15 | 0.03 | |||||
EBITDA Margin % | 26.02 | 20.15 | 18.22 | 19.66 | 19.94 | |||||
EBITA Margin % | 21.58 | 15.1 | 12.53 | 14.28 | 14.49 | |||||
EBIT Margin % | 20.13 | 13.54 | 11.01 | 12.92 | 13.21 | |||||
Income From Continuing Operations Margin % | 11.66 | 9.03 | 4.72 | 5.83 | 6.48 | |||||
Net Income Margin % | 11.65 | 9.09 | 4.76 | 5.85 | 6.51 | |||||
Net Avail. For Common Margin % | 11.14 | 8.65 | 3.94 | 5.13 | 5.7 | |||||
Normalized Net Income Margin | 11.57 | 7.27 | 5.91 | 6.98 | 7.18 | |||||
Levered Free Cash Flow Margin | 12.89 | 7.46 | 7.86 | 11.66 | 6.75 | |||||
Unlevered Free Cash Flow Margin | 13.66 | 8.26 | 8.97 | 12.91 | 8.01 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.75 | 0.69 | 0.62 | 0.64 | 0.67 | |||||
Fixed Assets Turnover | 3.95 | 3.36 | 2.92 | 2.86 | 2.74 | |||||
Receivables Turnover (Average Receivables) | 5.2 | 4.92 | 4.79 | 5 | 5.17 | |||||
Inventory Turnover (Average Inventory) | 30.87 | 34.6 | 36.12 | 38.38 | 40.22 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.25 | 1.31 | 1.45 | 1.16 | 1.09 | |||||
Quick Ratio | 1.13 | 1.18 | 1.34 | 1.05 | 1 | |||||
Operating Cash Flow to Current Liabilities | 0.81 | 0.64 | 0.48 | 0.63 | 0.58 | |||||
Days Sales Outstanding (Average Receivables) | 70.16 | 74.25 | 76.26 | 73.22 | 70.58 | |||||
Days Outstanding Inventory (Average Inventory) | 11.82 | 10.55 | 10.11 | 9.54 | 9.07 | |||||
Average Days Payable Outstanding | 22.87 | 23.63 | 24.41 | 24.26 | 25.01 | |||||
Cash Conversion Cycle (Average Days) | 59.11 | 61.17 | 61.95 | 58.49 | 54.65 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 58.88 | 68.55 | 76.43 | 67.05 | 96.84 | |||||
Total Debt / Total Capital | 37.06 | 40.67 | 43.32 | 40.14 | 49.2 | |||||
LT Debt/Equity | 53.46 | 64.15 | 64.73 | 58.15 | 80.96 | |||||
Long-Term Debt / Total Capital | 33.65 | 38.06 | 36.69 | 34.81 | 41.13 | |||||
Total Liabilities / Total Assets | 49.88 | 51.89 | 52.82 | 50.55 | 58.34 | |||||
EBIT / Interest Expense | 14.34 | 9.92 | 5.81 | 6.13 | 6.26 | |||||
EBITDA / Interest Expense | 19.92 | 16.26 | 10.85 | 10.45 | 10.52 | |||||
(EBITDA - Capex) / Interest Expense | 15.07 | 9.97 | 6.97 | 7.35 | 5.58 | |||||
Total Debt / EBITDA | 1.47 | 2.23 | 2.93 | 2.36 | 2.74 | |||||
Net Debt / EBITDA | 1.19 | 1.9 | 2.02 | 1.96 | 2.25 | |||||
Total Debt / (EBITDA - Capex) | 1.94 | 3.64 | 4.56 | 3.35 | 5.16 | |||||
Net Debt / (EBITDA - Capex) | 1.57 | 3.1 | 3.14 | 2.78 | 4.24 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 23.51 | -0.08 | -2.94 | 6.7 | 4.96 | |||||
Gross Profit, 1 Yr. Growth % | 35.47 | -19.74 | -9.13 | 14.41 | 5.71 | |||||
EBITDA, 1 Yr. Growth % | 37.19 | -22.63 | -12.23 | 15.15 | 6.46 | |||||
EBITA, 1 Yr. Growth % | 43.95 | -30.12 | -19.43 | 21.59 | 6.51 | |||||
EBIT, 1 Yr. Growth % | 49.52 | -33.09 | -21.1 | 25.22 | 7.34 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 44.89 | -22.63 | -49.21 | 31.78 | 16.65 | |||||
Net Income, 1 Yr. Growth % | 45.09 | -22.03 | -49.16 | 31.01 | 16.83 | |||||
Normalized Net Income, 1 Yr. Growth % | 55.93 | -37.51 | -21.03 | 25.85 | 8.06 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 44.57 | -21.72 | -55.48 | 40.77 | 21.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.4 | -3.42 | 2.89 | 1.45 | 1.49 | |||||
Inventory, 1 Yr. Growth % | -1.78 | -5.58 | -4.53 | 2.09 | -1.83 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 16.19 | 18.46 | 5.98 | 11.42 | 7.93 | |||||
Total Assets, 1 Yr. Growth % | 8.83 | 8.05 | 7.98 | -0 | 0.89 | |||||
Tangible Book Value, 1 Yr. Growth % | -44.88 | 82.02 | -59.17 | 7.26 | 177.65 | |||||
Common Equity, 1 Yr. Growth % | 25.94 | 2.89 | 6.18 | 5.15 | -14.9 | |||||
Cash From Operations, 1 Yr. Growth % | 23.4 | -24.82 | -10.42 | 29.57 | 6.07 | |||||
Capital Expenditures, 1 Yr. Growth % | 47.2 | 29.64 | -17.01 | -5.12 | 67.53 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 9.2 | -42.8 | 2.22 | 58.34 | -39.24 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 7.54 | -39.94 | 5.43 | 53.57 | -34.91 | |||||
Dividend Per Share, 1 Yr. Growth % | 47.06 | 0 | -50 | 20 | 20 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.34 | 11.09 | -1.52 | 1.76 | 5.83 | |||||
Gross Profit, 2 Yr. CAGR % | 43.39 | 3.94 | -14.98 | 1.55 | 9.69 | |||||
EBITDA, 2 Yr. CAGR % | 48.28 | 3.03 | -17.59 | 0.53 | 10.72 | |||||
EBITA, 2 Yr. CAGR % | 61.43 | 0.3 | -24.97 | -1.03 | 13.8 | |||||
EBIT, 2 Yr. CAGR % | 72.13 | 0.24 | -27.34 | -0.6 | 15.93 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 100.28 | 5.88 | -37.31 | -18.19 | 23.98 | |||||
Net Income, 2 Yr. CAGR % | 100.23 | 6.36 | -37.04 | -18.39 | 23.72 | |||||
Normalized Net Income, 2 Yr. CAGR % | 85.25 | -1.06 | -29.75 | -0.31 | 16.62 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 118.68 | 6.39 | -40.96 | -20.83 | 30.97 | |||||
Accounts Receivable, 2 Yr. CAGR % | 17.79 | 6.03 | -0.31 | 2.17 | 1.47 | |||||
Inventory, 2 Yr. CAGR % | 39.45 | -3.7 | -5.06 | -1.28 | 0.11 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 7.16 | 17.32 | 12.05 | 8.67 | 9.66 | |||||
Total Assets, 2 Yr. CAGR % | 9.22 | 8.44 | 8.02 | 3.91 | 0.44 | |||||
Tangible Book Value, 2 Yr. CAGR % | -53.62 | 0.17 | -13.8 | -33.83 | 72.57 | |||||
Common Equity, 2 Yr. CAGR % | 27.96 | 13.84 | 4.52 | 5.66 | -5.41 | |||||
Cash From Operations, 2 Yr. CAGR % | 49.24 | -3.63 | -17.93 | 7.74 | 17.23 | |||||
Capital Expenditures, 2 Yr. CAGR % | 28.24 | 36.15 | 3.72 | -11.27 | 26.07 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 40.93 | -20.54 | -23.53 | 27.22 | -1.91 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 36.29 | -19.41 | -20.43 | 27.24 | -0.02 | |||||
Dividend Per Share, 2 Yr. CAGR % | 70.25 | 21.27 | -29.29 | -22.54 | 20 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 21.12 | 13.73 | 6.2 | 1.14 | 2.82 | |||||
Gross Profit, 3 Yr. CAGR % | 38.54 | 17.92 | -0.9 | -6.38 | 2.74 | |||||
EBITDA, 3 Yr. CAGR % | 35.18 | 19.38 | -2.33 | -7.87 | 2.47 | |||||
EBITA, 3 Yr. CAGR % | 41.79 | 22.12 | -6.77 | -11.87 | 1.42 | |||||
EBIT, 3 Yr. CAGR % | 46.42 | 25.8 | -7.45 | -12.89 | 1.98 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 51.88 | 45.86 | -17.12 | -19.7 | -7.92 | |||||
Net Income, 3 Yr. CAGR % | 51.76 | 46.22 | -16.84 | -19.62 | -8.02 | |||||
Normalized Net Income, 3 Yr. CAGR % | 48.71 | 29.15 | -8.22 | -14.68 | 2.41 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 57.32 | 55.27 | -20.43 | -21.13 | -8.59 | |||||
Accounts Receivable, 3 Yr. CAGR % | 17.11 | 10.25 | 4.97 | 0.27 | 1.94 | |||||
Inventory, 3 Yr. CAGR % | 32.43 | 22.45 | -3.98 | -2.73 | -1.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.59 | 10.8 | 13.41 | 11.84 | 8.42 | |||||
Total Assets, 3 Yr. CAGR % | 9 | 8.83 | 8.29 | 5.28 | 2.9 | |||||
Tangible Book Value, 3 Yr. CAGR % | -40.17 | -26.84 | -25.73 | -7.28 | 6.73 | |||||
Common Equity, 3 Yr. CAGR % | 20.3 | 18.99 | 11.22 | 4.73 | -1.69 | |||||
Cash From Operations, 3 Yr. CAGR % | 40.54 | 18.79 | -5.95 | -4.44 | 7.18 | |||||
Capital Expenditures, 3 Yr. CAGR % | 12.4 | 27.46 | 15.44 | 0.69 | 9.67 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 61.96 | 4.72 | -13.58 | -2.54 | -0.55 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 56.07 | 3.91 | -11.86 | -0.93 | 1.77 | |||||
Dividend Per Share, 3 Yr. CAGR % | 51.43 | 42.58 | -9.74 | -15.66 | -10.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 21.5 | 17.7 | 11.49 | 8.78 | 6.05 | |||||
Gross Profit, 5 Yr. CAGR % | 31.89 | 22.35 | 13.82 | 10.88 | 3.04 | |||||
EBITDA, 5 Yr. CAGR % | 29.91 | 19.75 | 10.9 | 11.45 | 2.69 | |||||
EBITA, 5 Yr. CAGR % | 32.85 | 20.92 | 9.92 | 12.27 | 0.97 | |||||
EBIT, 5 Yr. CAGR % | 33.47 | 20.94 | 10.73 | 14.49 | 1.28 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 34.56 | 22.59 | 6.6 | 15.74 | -2.63 | |||||
Net Income, 5 Yr. CAGR % | 35.08 | 23 | 6.74 | 15.8 | -2.52 | |||||
Normalized Net Income, 5 Yr. CAGR % | 35.19 | 20.91 | 10.27 | 16.45 | 1.01 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 35.52 | 23.98 | 6.3 | 18.6 | -2.87 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.51 | 13.71 | 9.8 | 6.94 | 3.56 | |||||
Inventory, 5 Yr. CAGR % | 31.28 | 22.96 | 15.92 | 12.34 | -2.36 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 29.28 | 25.87 | 17.68 | 9.94 | 11.9 | |||||
Total Assets, 5 Yr. CAGR % | 17.71 | 11.57 | 8.61 | 6.84 | 5.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 1.31 | -3.68 | -30.76 | -29.72 | 4.06 | |||||
Common Equity, 5 Yr. CAGR % | 23.35 | 14.38 | 13.72 | 13.47 | 4.25 | |||||
Cash From Operations, 5 Yr. CAGR % | 32.35 | 22.91 | 13.35 | 14.24 | 2.72 | |||||
Capital Expenditures, 5 Yr. CAGR % | 24.05 | 23.48 | 8.21 | 10.27 | 19.58 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 45.41 | 24.54 | 20.22 | 13.2 | -9.09 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 39.43 | 22.92 | 19.34 | 12.68 | -7.3 | |||||
Dividend Per Share, 5 Yr. CAGR % | 37.97 | 33.03 | 11.66 | 11.7 | 1.15 |
- Stock Market
- Equities
- ERF Stock
- Financials Eurofins Scientific SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















